Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events.
Konttinen L, Honkanen V, Uotila T, Pöllänen J, Waahtera M, Romu M, Puolakka K, Vasala M, Karjalainen A, Luukkainen R, Nordström DC; ROB-FIN study group.
Konttinen L, et al. Among authors: vasala m.
Rheumatol Int. 2006 Aug;26(10):916-22. doi: 10.1007/s00296-005-0097-9. Epub 2006 Jan 10.
Rheumatol Int. 2006.
PMID: 16402217